Suppr超能文献

上皮性卵巢癌淋巴结转移的模式及临床预测因素

Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer.

作者信息

Harter P, Gnauert K, Hils R, Lehmann T G, Fisseler-Eckhoff A, Traut A, du Bois A

机构信息

Department of Gynecology, Dr Horst Schmidt Klinik (HSK), Wiesbaden, Germany.

出版信息

Int J Gynecol Cancer. 2007 Nov-Dec;17(6):1238-44. doi: 10.1111/j.1525-1438.2007.00931.x. Epub 2007 Apr 12.

Abstract

Para-aortic lymphadenectomy is part of staging in early epithelial ovarian cancer (EOC) and could be part of therapy in advanced EOC. However, only a minority of patients receive therapy according to guidelines or have attendance to a specialized unit. We analyzed pattern of lymphatic spread of EOC and evaluated if clinical factors and intraoperative findings reliably could predict lymph node involvement, in order to evaluate if patients could be identified in whom lymphadenectomy could be omitted and who should not be referred to a center with capacity of performing extensive gynecological operations. Retrospective analysis was carried out of all patients with EOC who had systematic pelvic and para-aortic lymphadenectomy during primary cytoreductive surgery. One hundred ninety-five patients underwent systematic pelvic and para-aortic lymphadenectomy. Histologic lymph node metastases were found in 53%. The highest frequency was found in the upper left para-aortic region (32% of all patients) and between vena cava inferior and abdominal aorta (36%). Neither intraoperative clinical diagnosis nor frozen section of pelvic nodes could reliably predict para-aortic lymph node metastasis. The pathologic diagnosis of the pelvic nodes, if used as diagnostic tool for para-aortic lymph nodes, showed a sensitivity of only 50% in ovarian cancer confined to the pelvis and 73% in more advanced disease. We could not detect any intraoperative tool that could reliably predict pathologic status of para-aortic lymph nodes. Systematic pelvic and para-aortic lymphadenectomy remains part of staging in EOC. Patients with EOC should be offered the opportunity to receive state-of-the-art treatment including surgery.

摘要

腹主动脉旁淋巴结切除术是早期上皮性卵巢癌(EOC)分期的一部分,也可能是晚期EOC治疗的一部分。然而,只有少数患者按照指南接受治疗或就诊于专科单位。我们分析了EOC的淋巴扩散模式,并评估临床因素和术中发现是否能可靠地预测淋巴结受累情况,以便评估是否能识别出可以省略淋巴结切除术的患者以及哪些患者不应转诊至有能力进行广泛妇科手术的中心。对所有在初次肿瘤细胞减灭术中接受系统性盆腔和腹主动脉旁淋巴结切除术的EOC患者进行了回顾性分析。195例患者接受了系统性盆腔和腹主动脉旁淋巴结切除术。组织学检查发现淋巴结转移的比例为53%。最高发生率出现在腹主动脉旁左上方区域(占所有患者的32%)以及下腔静脉和腹主动脉之间(36%)。术中临床诊断和盆腔淋巴结冰冻切片均不能可靠地预测腹主动脉旁淋巴结转移。如果将盆腔淋巴结的病理诊断用作腹主动脉旁淋巴结的诊断工具,在局限于盆腔的卵巢癌中敏感性仅为50%,在更晚期疾病中为73%。我们未能发现任何能可靠预测腹主动脉旁淋巴结病理状态的术中工具。系统性盆腔和腹主动脉旁淋巴结切除术仍然是EOC分期的一部分。EOC患者应有机会接受包括手术在内的最先进治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验